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Abstract: A new polyoxygenated sterol, sterolic acid (1), three new breviane 
spiroditerpenoids, breviones I–K (2–4), and the known breviones (5–8), were isolated from 
the crude extract of a Penicillium sp. obtained from a deep sea sediment sample that   
was collected at a depth of 5115 m. The structures of 1–4 were elucidated primarily by  
NMR experiments, and 1 was further confirmed by X-ray crystallography. The absolute 
configurations of 2 and 3 were deduced by comparison of their CD spectra with those of 
the model compounds. Compounds 2 and 5 showed significant cytotoxicity against MCF-7 
cells, which is comparable to the positive control cisplatin. 
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1. Introduction 
Marine-derived fungi are recognized as an important source of structurally diverse and 
pharmacologically active natural products [1,2]. In particular, a growing number of deep sea sediments 
derived fungi have been reported to produce novel bioactive secondary metabolites [3–9]. During an 
ongoing search for new cytotoxic natural products from fungi of unique habitats, we initiated chemical 
investigations of those fungi isolated from the deep sea sediment samples. In our previous study, we 
have characterized three new breviane spiroditerpenoids cytotoxic to HeLa Cells from the culture of a 
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Penicillium sp. obtained from a deep sea sediment sample that was collected at a depth of 5115 m [8]. 
Since the crude extract also showed cytotoxicity against two other human tumor cell lines, MCF-7 
(breast cancer cells) and A549 (lung carcinoma epithelial cells), and its HPLC fingerprint revealed the 
presence of minor components that could not be identified. Therefore, the fungus was refermented in a 
larger scale using the same solid-substrate fermentation medium in which the spiroditerpenoids were 
first isolated [8]. Fractionation of an EtOAc extract afforded a new polyoxygenated sterol, sterolic acid (1), 
three new breviane spiroditerpenoids, breviones I–K (2–4), and four known compounds, breviones A (5), 
B (6), F (7), and G (8) (Figure 1) [8,10,11]. Details of the isolation, structure elucidation, and 
cytotoxicity evaluation of these compounds are reported herein. 
Figure 1. Structures of compounds 1–9. 
 
2. Results and Discussion 
The molecular formula of sterolic acid (1) was established as C28H36O7 (11 degrees of unsaturation) 
on the basis of its HRESIMS (m/z = 507.2361 [M + Na]
+, Δ = −0.8 mmu). Analysis of the 
1H,  
13C NMR, and HMQC data (Table 1) of 1 revealed four methyl groups, five methylene units, nine 
methines including four oxymethines, four sp
3 quaternary carbons (two of which are oxygenated), four 
olefinic carbons (three of which are protonated), one α,β-unsaturated ketone carbon (δC 189.8), and 
one carboxylic carbon (δC 180.1), which are characteristic of the C28-ergostane-type sterol skeleton. 
Interpretation of the 
1H–
1H COSY NMR data established three spin systems, C-1–C-4, C-11–C-12, 
and C-14–C-17–C-20–C-28 (Figure 2), which were supported by relevant HMBC correlations. The 
connectivities of the above mentioned fragments and the remaining functional groups were established 
on the basis of the key HMBC correlations illustrated in Figure 2, completing the 3-hydroxy-7,22-
dien-6-one sterol nucleus. HMBC cross-peaks from H-24, H-25, and H3-26 to the C-27 carboxylic 
carbon (δC 180.1) connected the carboxyl group to C-25. A key HMBC correlation of H2-18 with  
C-9 revealed an ether linkage between C-18 and C-9 to form an oxabicyclo[2.2.2]octane moiety. Mar. Drugs 2012, 10 499 
 
 
Considering the unusual upfield chemical shifts for the oxygenated carbons, C-1 (δC 58.9), C-2   
(δC 52.6), C-4 (δC 55.4), and C-5 (δC 66.2), and the unsaturation requirement for 1, the presence of two 
epoxy units was evident. Collectively, these data permitted assignment of the gross structure of 1. 
Table 1. NMR data of sterolic acid (1) in CDCl3. 
Position  δC 
a, mult.  δH 
b (J in Hz)  HMBC (H→C#) 
1  58.9, CH  3.45, s  2, 5, 10, 19 
2  52.6, CH  3.35, s  4 
3  64.7, CH  4.25, s   
4  55.4, CH  3.94, s  2, 3 
5 66.2,  qC     
6 189.8,  qC     
7  122.6, CH  5.96, s  5, 9, 14 
8 167.8,  qC     
9 74.1,  qC     
10 38.9,  qC     
11a 30.6,  CH2  1.43, m   
11b    2.51, m  8, 9 
12a 30.9,  CH2  2.29, m  11, 13 
12b   2.31,  m  13 
13 42.8,  qC     
14  51.3, CH  2.62, t (9.7)  7, 8, 15, 18 
15a 25.1,  CH2  1.69, m  16 
15b    1.97, m  16, 17 
16a 29.6,  CH2  1.54, m  20, 17 
16b    2.00, m  13, 15 
17  49.8, CH  1.59, m  16, 20 
18a 65.6,  CH2  3.85, d (6.3)  9, 12, 13, 14 
18b    3.92, d (6.3)  12, 13, 14 
19 19.1,  CH3  1.15, s  1, 5, 9, 10 
20  38.9, CH  2.02, m  16 
21 21.4,  CH3  1.06, d (6.7)  17, 20, 22 
22  136.3, CH  5.28, dd (15.0, 8.0)  20, 24 
23  130.6, CH  5.19, dd (15.0, 8.0)  20, 24 
24  39.6, CH  2.42, q (6.9)  22,  23,  25,  26,  27, 
28 
25  44.8, CH  2.34, q (6.8)  23, 24, 26, 27, 28 
26 14.0,  CH3  1.10, d (6.8)  24, 25, 27 
27 180.1,  qC     
28 18.8,  CH3  1.04, d (6.9)  23, 24, 25 
a Recorded at 100 MHz; 
b Recorded at 500 MHz. Mar. Drugs 2012, 10 500 
 
 
Figure 2. Selected 
1H–
1H COSY and HMBC correlations in 1. 
 
The geometry of the C-22/C-23 olefin was deduced to be trans on the basis of the large coupling 
constant (J22,23 = 15.0 Hz) observed for the olefinic protons. The relative configuration of other 
stereogenic centers in 1 was assigned by single crystal X-ray crystallographic analysis (Figure 3). The 
chemical shift of H3-21 (δH 1.06) supported the 20R absolute configuration (H3-21 signal appears at 
1.04 and 0.94 ppm for 20R  and 20S  ∆
22-sterols, respectively) [12–14]. Considering the relative 
configuration established by X-ray data, the absolute configuration of 1 was determined as shown. 
Figure 3. Thermal ellipsoid representation of 1. 
 
Brevione I (2) was assigned the elemental composition C27H34O5 (11 degrees of unsaturation) by 
HRESIMS (m/z 461.2298 [M + Na]
+; Δ = +0.2 mmu). Analysis of its 
1H and 
13C NMR spectroscopic 
data (Table 2) revealed the presence of one exchangeable proton (δH 4.01), seven methyl groups, three 
methylenes, three methines including one oxymethine, four sp
3 quaternary carbons (one oxygenated), 
eight olefinic carbons (three of which are protonated), one ester carbonyl carbon (δC 171.3), and one 
α,β-conjugated ketone carbon (δC 203.9). Interpretation of the 
1H–
1H COSY and HMBC NMR data of 
2 established the gross structure of a spiroditerpenoid, which was the C-11 hydroxylated analogue of 
the known compound brevione A (5), a co-isolated known metabolite which was originally identified 
from a terrestrial Penicillium sp. [10]. The relative configuration of 2 was assigned on the basis of 
NOESY data and by analogy to 5. NOESY correlations of H-9 with H-5 and H-11, and of H-5 with Mar. Drugs 2012, 10 501 
 
 
H3-19 indicated that these protons are all on the same face of the ring system, whereas those of H3-17 
with H2-15 and H3-20, and of H3-18 with H3-20 were used to place them on the opposite face of the 
molecule, thereby establishing the relative configuration of 2. The CD spectra of 2 and 5 were nearly 
identical (Figure 4), suggesting the same absolute configuration for both compounds. 
Table 2. 
1H and 
13C NMR data of breviones I–K (2–4) in Acetone-d6. 
  Breviones I (2)    Breviones J (3)    Breviones K (4) 
Position  δC 
a, mult.  δH 
b (J in Hz)    δC 
c, mult.  δH 
b (J in Hz)    δC 
c, mult.  δH 
b (J in Hz) 
1a 
158.4, CH  7.50, d (11) 
 
38.4, CH2 
2.29, ddd (16, 6.0, 
3.2)
  155.2, CH  6.83, d (13) 
1b          2.34, ddd (16, 6.0, 
3.2) 
 
  
2a 
125.6, CH  5.80, d (11) 
 
33.8, CH2 
2.69, ddd (16, 6.0, 
3.2)
  128.4, CH  5.70, dd (13, 
2.1) 
2b          2.74, ddd (16, 6.0, 
3.2) 
    
3  203.9, qC      215.1, qC      192.5, qC   
4  44.8, qC      50.8, qC      154.0, qC   
5  54.6, CH  1.63, m    56.3, CH  1.75, m    48.6, CH  2.93, d (13) 
6a 19.3,  CH2  1.64, m    18.8, CH2  1.63, m    21.7, CH2  1.83, dt (13, 3.5) 
6b    1.80, m      1.82, m 1.93, td (13, 3.5)
7a 33.0,  CH2  1.50, m    32.3, CH2  1.48, m    30.3, CH2  1.65, td (13, 3.5) 
7b    1.62, m      1.56, m      1.74, dt (13, 3.5) 
8  41.9, qC      40.8, qC      45.4, qC   
9  47.1, CH  1.95, d (4.5)    47.2, CH  1.91, br    54.8, CH  3.15, s 
10  41.3, qC      40.2, qC      42.0, qC   
11  64.4, CH  4.78, s    64.1, CH  4.51, s    198.2, qC   
12  131.3, CH  5.79, s    131.0, CH  5.72, d (5.0)    130.2, CH  5.91, s 
13  133.1, qC      132.2, qC      151.8, qC   
14  99.8, qC      99.1, qC      97.7, qC   
15a 29.5,  CH2  2.96, d (16)    29.7, CH2  2.94, d (16)    30.1, CH2 3.15,  s 
15b    3.01, d (16)      2.97, d (16)  
16 18.8,  CH3 1.74,  s   18.2,  CH3 1.71,  s  18.5,  CH3 1.97,  s 
17 20.0,  CH3 1.32,  s   16.7,  CH3 1.29,  s  18.3,  CH3 1.18,  s 
18 27.8,  CH3 1.08,  s   26.0,  CH3 1.05,  s   131.7, CH  5.99, s 
19 22.2,  CH3 1.06,  s   21.4,  CH3 1.01,  s  24.1,  CH3 1.99,  s 
20 21.5,  CH3 1.67,  s   19.4,  CH3 1.59,  s  14.3,  CH3 1.41,  s 
1'  171.3, qC      170.6, qC      170.8, qC   
2'  99.8, qC      99.3, qC      100.1, qC   
3'  161.2, qC      159.4, qC      161.8, qC   
4'  103.0, qC      102.4, qC      103.2, qC   
5' 161.0,  qC     160.4,  qC     160.7,  qC   
6' 9.5,  CH3 1.85,  s   8.7,  CH3 1.86,  s  9.5,  CH3 1.92,  s 
7' 17.1,  CH3 2.17,  s   16.4,  CH3 2.17,  s  17.2,  CH3 2.20,  s 
OH-11    4.01, br      3.72, d (5.0)       
a Recorded at 100 MHz; 
b Recorded at 500 MHz; 
c Recorded at 150 MHz. Mar. Drugs 2012, 10 502 
 
 
Brevione J (3) gave a pseudomolecular ion [M + Na]
+ peak at m/z = 463.2455 (Δ = +0.7 mmu) by 
HRESIMS, consistent with an elemental composition of C27H36O5 (10 degrees of unsaturation). 
Analysis of its NMR data (Table 2) revealed the presence of similar structural features as those found 
in  2, except that the C-1/C-2 olefin was replaced by two mutually-coupled methylenes, and this 
observation was supported by relevant 
1H–
1H COSY and HMBC correlations. Therefore, the planar 
structure of 3 was proposed as shown. NOESY correlations of H-5 with H-9 and H3-19, and of H-9 
with H-11 indicated that these protons are all on the same face of the ring system, whereas those of  
H3-17 with H-6b, H2-15 and H3-20, and of H-6b with H3-18 were used to place them on the opposite 
face of the molecule, thereby establishing the relative configuration of 3. The absolute configuration of 
3 was deduced to be the same as that of the co-isolated known compound 6 [11] by comparison of their 
NMR and CD data (Figure 4). 
Figure 4. CD spectra of compounds 2, 3, 5, and 6. 
 
Brevione K (4) was isolated as a yellow powder with a molecular formula of C27H30O5 (13 degrees 
of unsaturation), established by HRESIMS (m/z 457.1985 [M + Na]
+; Δ = +0.5 mmu). The 
1H and  
13C NMR spectra of 4 (Table 2) showed resonances similar to those of the co-isolated known 
compounds, breviones F (7) and G (8) [8], except that the C-11 oxymethine was replaced by an  
α,β-conjugated ketone carbon (δC 198.2), which was confirmed by an HMBC correlation from H-9 to 
C-11. The relative configuration of 4 was assigned on the basis of NOESY data and by analogy to 7 
and 8. A NOESY correlation of H-9 with H-5 placed the two protons on the same face of the ring 
system, whereas those of H3-17 with H2-15 and H3-20 indicated that these protons were on the 
opposite face, establishing the relative configuration of 4. The absolute configuration of 4 was deduced by 
semisynthetic method [15]. Specifically, treatment of 7 and 8 with manganese dioxide both afforded an 
oxidation product of OH-11, and the 
1H NMR data and specific rotation value of the product were 
identical to 4, suggesting the 5S, 8R, 9R, 10S, and 14S absolute configuration. 
Compounds 1–8 were tested for cytotoxicity against two human tumor cell lines, MCF-7 and A549. 
Compounds 2 and 5 showed cytotoxic effects against MCF-7 cells, with IC50 values of 7.44 and   
28.4 µM, respectively, whereas 2 also displayed activity against A549 cells, with an IC50 value of   
32.5 µM (the positive control cisplatin showed IC50 values of 8.09 and 8.90 µM, respectively, against Mar. Drugs 2012, 10 503 
 
 
the two tumor cell lines). Other compounds did not show detectable cytotoxicity against the two cell 
lines at 50 µg/mL. 
3. Experimental Section  
3.1. General Experimental Procedures 
Optical rotations were measured on a Perkin-Elmer 241 polarimeter, and UV data were recorded  
on a Shimadzu Biospec-1601 spectrophotometer. CD spectra were recorded on a JASCO J-815 
spectropolarimeter. IR data were recorded using a Nicolet Magna-IR 750 spectrophotometer. 
1H and 
13C NMR data were acquired with Varian Mercury-400, Inova-500 and NMR system-600 spectrometers 
using solvent signals (acetone-d6: δH 2.05/δC 29.8, 206.1; CDCl3: δH 7.26/δC 76.7) as references. The 
HMQC and HMBC experiments were optimized for 145.0 and 8.0 Hz, respectively. ESIMS data were 
recorded on a Bruker Esquire 3000
plus spectrometer, and HRESIMS data were obtained using Bruker 
APEX III 7.0 T and APEX II FT-ICR spectrometers, respectively. 
3.2. Fungal Material 
The Penicillium sp. was isolated by one of the authors (D.Y.) from a deep water sediment sample 
collected at a depth of 5115 m in the East Pacific Ocean (145°2′W, 07°37′N), in September 2003. The 
isolate was characterized as an unidentified species of Penicillium by one of authors (Z.S.) based on 
sequence (Genebank accession number EU139854) analysis of the ITS region of the rDNA and 
assigned the accession number 3A00005 in the Marine Culture Collection Center (MCCC) at the Third 
Institute of Oceanography, the State Oceanic Administration, Xiamen, People’s Republic of China. 
The fungal strain was cultured on slants of potato dextrose agar (PDA) with artificial seawater   
(NaCl 23.5 g, MgCl2·6H2O 10.6 g, CaCl2·2H2O 1.5 g, KCl 0.66 g, Na2SO4 3.9 g, NaHCO3 0.2 g, 
H3BO3 0.03 g in 1 L distilled H2O) at 25 °C for 7 days. Agar plugs were cut into small pieces   
(about 0.5 × 0.5 × 0.5 cm
3) under aseptic conditions, 15 pieces were used to inoculate in three 
Erlenmeyer flasks (250 mL), each containing 50 mL of media (0.4% glucose, 1% malt extract, and 
0.4% yeast extract in artificial seawater); the final pH of the media was adjusted to 6.5 and sterilized 
by autoclave. Three flasks of the inoculated media were incubated at 25 °C on a rotary shaker at  
170 rpm for five days to prepare the seed culture. Fermentation was carried out in 12 Fernbach flasks 
(500 mL), each containing 80 g of rice. Spore inoculum was prepared by suspension in sterile, distilled 
H2O to give a final spore/cell suspension of 1 × 10
6/mL. Artificial seawater (120 mL) was added to 
each flask, and the contents were soaked overnight before autoclaving at 15 psi for 30 min. After 
cooling to room temperature, each flask was inoculated with 5.0 mL of the spore inoculum and 
incubated at 25 °C for 40 days. 
3.3. Extraction and Isolation 
The fermented material was extracted repeatedly with EtOAc (4 × 1.0 L), and the organic solvent 
was evaporated to dryness under vacuum to afford the crude extract (7.5 g), which was fractionated by 
silica gel VLC using petroleum ether-EtOAc gradient elution. The fractions eluted with 40 (125 mg) 
and 45% (65 mg) EtOAc were combined and separated again by Sephadex LH-20 column chromatography Mar. Drugs 2012, 10 504 
 
 
(CC) using 1:1 CH2Cl2-MeOH as eluents, and the resulting subfractions were combined and further 
purified by semipreparative RP HPLC (Agilent Zorbax SB-C18 column; 5 μm; 9.4 × 250 mm; 43% 
CH3CN in H2O for 40 min; 2 mL/min) to afford breviones I (2; 5.2 mg, tR 37.22 min) and J (3; 3.6 mg, 
tR 38.81 min). The fraction (86 mg) eluted with 100% EtOAc was fractionated again by Sephadex  
LH-20 CC eluting with MeOH as eluents. One subfraction (28 mg) was further purified by RP HPLC 
(Agilent Zorbax SB-C18 column; 5 μm; 9.4 × 250 mm; 65% MeOH in H2O for 15 min followed by  
65–100% for 20 min; 2 mL/min) to afford sterolic acid (1; 6.0 mg, tR = 28.60 min). The fraction  
(120 mg) eluted with 15% EtOAc was separated again by Sephadex LH-20 CC eluting with 1:1 
CH2Cl2-MeOH. The resulting subfractions were combined and further purified by RP HPLC (85% MeOH 
in H2O for 25 min 2 mL/min) to afford 5 (18.0 mg, tR 16.04 min) and 6 (14.5 mg, tR 18.51 min). The 
fractions eluted with 50 (163 mg) and 60% (225 mg) EtOAc were combined and fractionated again by 
Sephadex LH-20 CC using 1:1 CH2Cl2-MeOH. Purification of the resulted subfractions with different 
isocratic elutions by RP HPLC afforded breviones K (4; 4.8 mg, tR 41.9 min; 65% CH3OH in H2O for 
45 min), F (7; 9.5 mg, tR 54.38 min; 58% CH3OH in H2O for 60 min), and G (8; 12.5 mg, tR 44.71 
min; same elution as in purification of 7), respectively. 
Sterolic acid (1): yellow powder; [α]
25
D −25 (c 0.1, MeOH); UV (MeOH) λmax (log ε) 202 (2.13), 
246 (2.31) nm; IR (neat) νmax 3379 (br), 2962, 2931, 2874, 1693, 1682, 1624, 1154, 1477, 1254, 1215, 
1057, 972 cm
−1; 
1H, 
13C NMR, and HMBC data see Table 1; HRESIMS m/z 507.2361 [M + Na]
+ 
(calcd. for C28H36O7Na, 507.2353). 
Brevione I (2): white powder; [α]
25
D +96 (c 0.1, CHCl3); UV (CH3OH) λmax (log ε) 212 (4.01),  
296 (2.28) nm; CD (c 4.6 × 10
−4 M, MeOH) λmax (Δε) 219 (+14.05), 241 (+23.34), 294 (−1.73), 341  
(−3.03); IR (neat) νmax 3436 (br), 2947, 1701, 1670, 1574, 1445, 1390, 1275, 1061, 984 cm
−1; 
1H and 
13C NMR data, see Table 2; HMBC data (acetone-d6, 400 MHz) H-1→C-3, 5, 9, 10; H-2→C-4, 10;  
H-5→C-1, 2, 7, 9, 18, 19, 20; H-6a→C-4, 10; H-6b→C-5; H-7a→C-5, 8, 14, 17; H-7b→C-6, 9;  
H-9→C-1, 5, 8, 10, 11, 12, 14, 17, 20; H-11→C-8, 9, 12, 13; H-12→C-9, 14; H-15a→C-8, 13, 14, 1', 
3'; H-15b→C-8, 13, 14, 1', 3'; H3-16→C-12, 13, 14; H3-17→C-7, 8, 9, 14; H-18→C-3, 4, 5, 19;  
H3-19→C-3, 4, 5, 18; H3-20→C-1, 5, 9, 10; H3-6'→C-1', 4', 5'; H3-7'→C-3', 4', 5'; NOESY correlations 
(acetone-d6, 400 MHz) H-1↔H-9, H-11, H3-20; H-2↔H-11; H-5↔H-9, H3-19; H-6a↔H-9, H3-19;  
H-6b↔H3-17, H3-18, H3-20; H-7a↔H-9; H-7b↔H-15b, H3-17; H-9↔H-1, H-5, H-6a, H-7a, H-11;  
H-11↔H-1, H-2, H-9; H-12↔H3-16; H-15a↔H3-16, H3-17; H-15b↔H-7b, H3-17; H3-16↔H-12,  
H-15a; H3-17↔H-6b, H-7b, H-15a, H-15b, H3-20; H3-18↔H-6b; H3-19↔H-5, H-6a; H3-20↔H-1,  
H-6b, H3-17; H3-6'↔H3-7'; HRESIMS m/z 461.2298 [M + Na]
+ (calcd. for C27H34O5Na, 461.2300). 
Brevione J (3): white powder; [α]
25
D +64 (c 0.1, CHCl3); UV (CH3OH) λmax (log ε) 212 (2.96), 244 
(3.38), 297 (3.30) nm; CD (c 4.6 × 10
−4 M, MeOH) λmax (Δε) 212 (+9.22), 244 (+10.03), 297 (−1.01); 
IR (neat) νmax 3494 (br), 2951, 1704, 1651, 1574, 1444, 1389, 1275, 1062, 983 cm
−1; 
1H and 
13C NMR 
data, see Table 2; NOESY correlations (acetone-d6, 600 MHz) H-1a↔H-5, H-9, H-11; H-1b↔H3-20;  
H-2a↔H-11; H-2b↔H3-20; H-5↔H-1a, H-9, H3-19; H-6a↔H-9, H3-19; H-6b↔H3-17, H3-18, H3-20; 
H-7a↔H-9; H-7b↔H-15b, H3-17; H-9↔H-1a, H-5, H-6a, H-7a, H-11; H-11↔H-1a, H-2a, H-9;   
H-12↔H3-16; H-15a↔H3-16, H3-17; H-15b↔H-7b, H3-17; H3-16↔H-12, H-15a; H3-17↔H-6b,  
H-7b, H-15a, H-15b, H3-20; H3-18↔H-6b; H3-19↔H-5, H-6a; H3-20↔H-1b, H-2b, H-6b, H3-17;  
H3-6'↔H3-7'; HRESIMS m/z 463.2455 [M + Na]
+ (calcd. for C27H36O5Na, 463.2462). Mar. Drugs 2012, 10 505 
 
 
Brevione K (4): yellow powder; [α]
25
D +34 (c 0.2, CHCl3); UV (CH3OH) λmax (log ε) 208 (3.60), 
234 (3.51), 294 (2.95) nm; IR (neat) νmax 2934, 1724, 1668, 1652, 1624, 1582, 1440, 1393, 1273, 1113 
cm
−1; 
1H and 
13C NMR data, see Table 2; HMBC data (acetone-d6, 600 MHz) H-1→C-3, 5, 9, 10;  
H-2→C-10, 18; H-6a→C-5, 8; H-6b→C-5, 7; H-7a→C-6, 17; H-7b→C-5, 6, 8, 17; H-9→C-1, 5, 10, 
11, 17, 20; H-12→C-9, 14, 16; H2-15→C-8, 13, 14, 1', 2', 3', 4'; H3-16→C-12, 13, 14; H3-17→C-7, 8, 
9, 14; H-18→C-2, 5, 19; H3-19→C-4, 5, 18; H3-20→C-1, 5, 9, 10; H3-6'→C-1', 4', 5'; H3-7'→C-4', 5'; 
NOESY correlations (acetone-d6, 600 MHz) H-1↔H-9; H-5↔H-9; H-6b↔H2-15, H3-17, H3-20;  
H-7b↔H2-15, H3-17; H-9↔H-1, H-5; H-12↔H3-16; H2-15↔H-6b, H-7b, H3-16, H3-17; H3-16↔H-12, 
H2-15; H3-17↔H-6b, H-7b, H2-15, H3-20; H-18↔H3-19; H3-20↔H-6b, H3-17; H3-6'↔H3-7'; 
HRESIMS m/z 457.1985 [M + Na]
+ (calcd. for C27H30O5Na, 457.1990). 
Brevione A (5): white powder; CD (c 4.6 × 10
−4 M, MeOH) λmax (Δε) 237 (+27.7), 294 (−1.38), 
341 (−3.93); 
1H, 
13C NMR, and the ESIMS data were fully consistent with literature [10]. 
Brevione B (6): white powder; CD (c 4.6 × 10
−4 M, MeOH) λmax (Δε) 212 (+10.96), 242 (+7.69), 
274 (−0.50); 
1H, 
13C NMR, and the ESIMS data were fully consistent with literature [11]. 
Brevione F (7): 
1H, 
13C NMR, and the ESIMS data were fully consistent with literature [8]. 
Brevione G (8): 
1H, 
13C NMR, and the ESIMS data were fully consistent with literature [8]. 
Oxidation of brevione F (7) to brevione K (4): A solution of brevione F (7; 1.5 mg, 0.034 mmol) 
in dry benzene (1.0 mL) was treated with MnO2 (3.0 mg, 0.034 mmol). The mixture was stirred at  
25 °C for 10 days, filtered, and washed with diethyl ether. The filtrate was concentrated under reduced 
pressure and the residue was purified by RP HPLC (Agilent Eclipse plus C18 column; 3.5 μm;  
4.6 × 100 mm; 20% MeOH in H2O for 1 min, followed by 20–100% over 15 min; 1 mL/min) to afford 
4 (0.6 mg, tR 12.88 min, 40% yield). 
Oxidation of brevione G (8) to brevione K (4): A solution of brevione G (8; 1.5 mg, 0.034 mmol) 
in dry benzene (1.0 mL) was treated with MnO2 (3.0 mg, 0.034 mmol). The mixture was stirred at  
25 °C for 10 days, filtered, and MnO2 was washed with diethyl ether. The filtrate was concentrated 
under reduced pressure and the residue was purified by RP HPLC (the same HPLC conditions as 
above) to afford 4 (0.5 mg, tR 12.88 min, 33% yield). 
3.4. X-ray Crystallographic Analysis of 1 
Upon crystallization from MeOH/H2O (10:1) using the vapor diffusion method, colorless crystals 
were obtained for 1, and a crystal (0.33 × 0.23 × 0.07 mm) was separated from the sample and 
mounted on a glass fiber, and data were collected using a Rigaku Saturn CCD area detector with 
graphite-monochromated Mo Kα radiation, λ = 0.71073 Ǻ at 173(2) K. Crystal data: C28H36O7,  
M = 484.57, space group orthorhombic, P212121; unit cell dimensions a  = 9.6480 (19) Å,   
b = 14.209 (3) Å, c = 18.550 (4) Å, V = 2543.0 (9) Å
3, Z = 4, Dcalcd = 1.266 mg/m
3, μ = 0.090 mm
−1, 
F(000) = 1040. The structure was solved by direct methods using SHELXL-97 [16] and refined using 
full-matrix least-squares difference Fourier techniques. All non-hydrogen atoms were refined with 
anisotropic displacement parameters, and all hydrogen atoms were placed in idealized positions and 
refined as riding atoms with the relative isotropic parameters. Absorption corrections were applied Mar. Drugs 2012, 10 506 
 
 
with the Siemens Area Detector Absorption Program (SADABS) [17]. The 2,5647 measurements 
yielded 5825 independent reflections after equivalent data were averaged, and Lorentz and polarization 
corrections were applied. The final refinement gave R1 = 0.0414 and wR2 = 0.0303 [I > 2σ(I)]. 
Crystallographic data for compound 1 have been deposited with the Cambridge Crystallographic   
Data Centre as supplementary publication number CCDC 859857. Copies of the data can be obtained, 
free of charge, on application to the director, CCDC 12 Union Road, Cambridge CB2 1EZ, UK [18]. 
3.5. MTS Assay 
The assay was run in triplicate. In a 96-well plate, each well was plated with (2–5) × 10
3 cells 
(depending on the cell multiplication rate). After cell attachment overnight, the medium was removed, 
and each well was treated with 100 µL medium containing 0.1% DMSO, or appropriate concentrations 
of the test compounds and the positive control cisplatin (100 mM as stock solution of a compound in 
DMSO and serial dilutions; the test compounds showed good solubility in DMSO and did not 
precipitate when added to the cells). The plate was incubated for 48 h at 37 °C in a humidified,  
5% CO2 atmosphere. Proliferation assessed by adding 20 μL of MTS (Promega) to each well in the 
dark, followed by a 90 min incubation at 37 °C. The assay plate was read at 490 nm using a microplate 
reader [19]. 
4. Conclusions  
Sterolic acid (1) is the first example of the sterols possessing the unusual 1,2:4,5-diepoxy, 
oxabicyclo[2.2.2]octane with a C-27 carboxylic group. Although the polyoxygenated sterols were 
encountered frequently in natural products, the diepoxy sterols are relatively rare, with only three 
marine-derived 5,6:8,9-diepoxy sterols as the reported precedents [20]. Sterols containing the 
oxabicyclo[2.2.2]octane moiety are also rare, only the plant metabolite 12β,14β-dihydroxy-3β,19-
epoxy-3a-methoxy-5a-card-20(22)-enolide has been reported to date [21]. Structurally, 1 is related to 
the known compound gargalol A (9), a sterol isolated from an edible mushroom Grifola gargal [22]. 
However,  1  differs significantly from 9 by having more complexed structural features. Breviones   
I–K (2–4) are new members of the breviane spiroditerpenoid class of metabolites with mixed   
biogenesis [8,10,11]. Compounds 2 and 3 are closely related to the known breviones A (5) and   
B (6) [10,11], respectively, but differ in having a hydroxy group at C-11, whereas compound 4 has a 
ketone group at C-11 compared to the co-isolated known compounds 7 and 8 [8]. To date, total 
syntheses of several breviane spiroditerpenoids have been achieved [23–27] including the 
enantioselective synthesis of breviones A–C [27]. In the current work, the isolation of additional new 
secondary metabolites, especially the structurally unique sterol demonstrated that the marine-derived 
fungi from deep water sediments deserve increased attention. 
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